Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil
Mycophenolate mofetil has been reported to be effective in the treatment of steroid-responsive minimal change disease. We report a case of steroid- and cyclosporin-resistant minimal change disease with severe nephrotic syndrome that responded to mycophenolate mofetil with complete remission. The pat...
Gespeichert in:
| Veröffentlicht in: | American journal of nephrology 2002-09, Vol.22 (5-6), p.569-572 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 572 |
|---|---|
| container_issue | 5-6 |
| container_start_page | 569 |
| container_title | American journal of nephrology |
| container_volume | 22 |
| creator | Mogyorósi, András Lippman, H. Robert Feldman, George M. |
| description | Mycophenolate mofetil has been reported to be effective in the treatment of steroid-responsive minimal change disease. We report a case of steroid- and cyclosporin-resistant minimal change disease with severe nephrotic syndrome that responded to mycophenolate mofetil with complete remission. The patient remains in complete remission 1 year after the discontinuation of mycophenolate mofetil. The presented case argues for the need of a prospective controlled study with the goal of evaluating the efficacy of mycophenolate mofetil in the therapy of steroid-resistant minimal change disease. |
| doi_str_mv | 10.1159/000065276 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20908348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21275467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-7ad34ac82add53aade4648aa8823c622d75bd38d859718ef34123a2f5b8652443</originalsourceid><addsrcrecordid>eNqF0c9rFDEUB_Agil2rB8-CDAWFHkbzO5ljWatVugq2njwMb5M33dTZyZrMUPrfm7pLF0RoLoHw4b3vyyPkJaPvGFPNe1qOVtzoR2TGJGd1ow19TGaUK1pb2qgD8izna0oZt9Q8JQeMC8sazWbk58XkHObcTX11mRDGNQ5jFbvqYsQUg6-_Yw55hPK4CENYQ1_NVzBcYfUhZISM1U0YV9Xi1sXNCofYw4jVInY4hv45edJBn_HF7j4kPz6eXs7P6vNvnz7PT85rJ6UZawNeSHCWg_dKAHiUWloAa7lwmnNv1NIL661qDLPYCVniA-_U0pahpRSH5O227ibF3xPmsV2H7LDvYcA45dZwZrTh4kHIGTdKavMwpA21QtoCj_6B13FKQ5m25Zwyqbm-a3u8RS7FnBN27SaVn0y3LaPt3QLb-wUW-3pXcFqu0e_lbmMFvNkByA76LsHgQt470ShruNon-wXpCtM9OPny9W-nduO7gl79F22z_AG_u7Vt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220146263</pqid></control><display><type>article</type><title>Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil</title><source>Karger Journals</source><source>MEDLINE</source><creator>Mogyorósi, András ; Lippman, H. Robert ; Feldman, George M.</creator><creatorcontrib>Mogyorósi, András ; Lippman, H. Robert ; Feldman, George M.</creatorcontrib><description>Mycophenolate mofetil has been reported to be effective in the treatment of steroid-responsive minimal change disease. We report a case of steroid- and cyclosporin-resistant minimal change disease with severe nephrotic syndrome that responded to mycophenolate mofetil with complete remission. The patient remains in complete remission 1 year after the discontinuation of mycophenolate mofetil. The presented case argues for the need of a prospective controlled study with the goal of evaluating the efficacy of mycophenolate mofetil in the therapy of steroid-resistant minimal change disease.</description><identifier>ISSN: 0250-8095</identifier><identifier>EISSN: 1421-9670</identifier><identifier>DOI: 10.1159/000065276</identifier><identifier>PMID: 12381961</identifier><identifier>CODEN: AJNED9</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Biological and medical sciences ; Case Report ; Drug Resistance ; Humans ; Immunomodulators ; Immunosuppressive Agents - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Mycophenolic Acid - analogs & derivatives ; Mycophenolic Acid - therapeutic use ; Nephrosis, Lipoid - drug therapy ; Pharmacology. Drug treatments ; Steroids - therapeutic use</subject><ispartof>American journal of nephrology, 2002-09, Vol.22 (5-6), p.569-572</ispartof><rights>2002 S. Karger AG, Basel</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 S. Karger AG, Basel</rights><rights>Copyright S. Karger AG Sep-Dec 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-7ad34ac82add53aade4648aa8823c622d75bd38d859718ef34123a2f5b8652443</citedby><cites>FETCH-LOGICAL-c447t-7ad34ac82add53aade4648aa8823c622d75bd38d859718ef34123a2f5b8652443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2423,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13958725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12381961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mogyorósi, András</creatorcontrib><creatorcontrib>Lippman, H. Robert</creatorcontrib><creatorcontrib>Feldman, George M.</creatorcontrib><title>Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil</title><title>American journal of nephrology</title><addtitle>Am J Nephrol</addtitle><description>Mycophenolate mofetil has been reported to be effective in the treatment of steroid-responsive minimal change disease. We report a case of steroid- and cyclosporin-resistant minimal change disease with severe nephrotic syndrome that responded to mycophenolate mofetil with complete remission. The patient remains in complete remission 1 year after the discontinuation of mycophenolate mofetil. The presented case argues for the need of a prospective controlled study with the goal of evaluating the efficacy of mycophenolate mofetil in the therapy of steroid-resistant minimal change disease.</description><subject>Biological and medical sciences</subject><subject>Case Report</subject><subject>Drug Resistance</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycophenolic Acid - analogs & derivatives</subject><subject>Mycophenolic Acid - therapeutic use</subject><subject>Nephrosis, Lipoid - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Steroids - therapeutic use</subject><issn>0250-8095</issn><issn>1421-9670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqF0c9rFDEUB_Agil2rB8-CDAWFHkbzO5ljWatVugq2njwMb5M33dTZyZrMUPrfm7pLF0RoLoHw4b3vyyPkJaPvGFPNe1qOVtzoR2TGJGd1ow19TGaUK1pb2qgD8izna0oZt9Q8JQeMC8sazWbk58XkHObcTX11mRDGNQ5jFbvqYsQUg6-_Yw55hPK4CENYQ1_NVzBcYfUhZISM1U0YV9Xi1sXNCofYw4jVInY4hv45edJBn_HF7j4kPz6eXs7P6vNvnz7PT85rJ6UZawNeSHCWg_dKAHiUWloAa7lwmnNv1NIL661qDLPYCVniA-_U0pahpRSH5O227ibF3xPmsV2H7LDvYcA45dZwZrTh4kHIGTdKavMwpA21QtoCj_6B13FKQ5m25Zwyqbm-a3u8RS7FnBN27SaVn0y3LaPt3QLb-wUW-3pXcFqu0e_lbmMFvNkByA76LsHgQt470ShruNon-wXpCtM9OPny9W-nduO7gl79F22z_AG_u7Vt</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Mogyorósi, András</creator><creator>Lippman, H. Robert</creator><creator>Feldman, George M.</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20020901</creationdate><title>Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil</title><author>Mogyorósi, András ; Lippman, H. Robert ; Feldman, George M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-7ad34ac82add53aade4648aa8823c622d75bd38d859718ef34123a2f5b8652443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Case Report</topic><topic>Drug Resistance</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycophenolic Acid - analogs & derivatives</topic><topic>Mycophenolic Acid - therapeutic use</topic><topic>Nephrosis, Lipoid - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Steroids - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mogyorósi, András</creatorcontrib><creatorcontrib>Lippman, H. Robert</creatorcontrib><creatorcontrib>Feldman, George M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mogyorósi, András</au><au>Lippman, H. Robert</au><au>Feldman, George M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil</atitle><jtitle>American journal of nephrology</jtitle><addtitle>Am J Nephrol</addtitle><date>2002-09-01</date><risdate>2002</risdate><volume>22</volume><issue>5-6</issue><spage>569</spage><epage>572</epage><pages>569-572</pages><issn>0250-8095</issn><eissn>1421-9670</eissn><coden>AJNED9</coden><abstract>Mycophenolate mofetil has been reported to be effective in the treatment of steroid-responsive minimal change disease. We report a case of steroid- and cyclosporin-resistant minimal change disease with severe nephrotic syndrome that responded to mycophenolate mofetil with complete remission. The patient remains in complete remission 1 year after the discontinuation of mycophenolate mofetil. The presented case argues for the need of a prospective controlled study with the goal of evaluating the efficacy of mycophenolate mofetil in the therapy of steroid-resistant minimal change disease.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>12381961</pmid><doi>10.1159/000065276</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0250-8095 |
| ispartof | American journal of nephrology, 2002-09, Vol.22 (5-6), p.569-572 |
| issn | 0250-8095 1421-9670 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_20908348 |
| source | Karger Journals; MEDLINE |
| subjects | Biological and medical sciences Case Report Drug Resistance Humans Immunomodulators Immunosuppressive Agents - therapeutic use Male Medical sciences Middle Aged Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Nephrosis, Lipoid - drug therapy Pharmacology. Drug treatments Steroids - therapeutic use |
| title | Successful Treatment of Steroid-Resistant Minimal Change Disease with Mycophenolate Mofetil |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T14%3A20%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20Treatment%20of%20Steroid-Resistant%20Minimal%20Change%20Disease%20with%20Mycophenolate%20Mofetil&rft.jtitle=American%20journal%20of%20nephrology&rft.au=Mogyor%C3%B3si,%20Andr%C3%A1s&rft.date=2002-09-01&rft.volume=22&rft.issue=5-6&rft.spage=569&rft.epage=572&rft.pages=569-572&rft.issn=0250-8095&rft.eissn=1421-9670&rft.coden=AJNED9&rft_id=info:doi/10.1159/000065276&rft_dat=%3Cproquest_cross%3E21275467%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220146263&rft_id=info:pmid/12381961&rfr_iscdi=true |